Trademark Overview
On Thursday, August 8, 2024, a trademark application was filed for CAELIMIR with the United States Patent and Trademark Office. The USPTO has given the CAELIMIR trademark a serial number of 79406277. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 10, 2024. This trademark is owned by ToxGenSolutions BV. The CAELIMIR trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:
Software relating to the pharmaceutical field; bioinformatics software; healthcare software; software relating to the medical field; software relating to research, discovery and development of pharmaceuticals, therapeutics and/or diagnostics; electronic databases for capturing, storing, processing, evaluating and reproducing pharmaceutical data; all of the aforementioned goods whether or not including artificial intelligence.
Providing temporary use of non-downloadable software for capturing, storing, processing, evaluating and reproducing pharmaceutical data; software as a service (SaaS) featuring health monitoring software; software as a service (SaaS) featuring bioinformatics software; scientific computer programming services; pharmaceutical research and development; research and development of mRNA-based therapeutics; research and development of mRNA-based diagnostics; research and development of mRNA drugs; research and development in the field of microorganisms and cells; pharmaceutical products development; pharmaceutical product evaluation; testing of pharmaceuticals; development of gene-based medicines; laboratory research services relating to pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; services for assessing the efficiency of pharmaceuticals; information technology services for the pharmaceutic...
